Concurrently, anti-inflammatory cytokines (IL-4 and IL-10) were up-regulated in BPD lungs as a compensatory mechanism; GSDMD deletion further amplified this anti-inflammatory arm, thereby mitigating overall inflammation (Supplementary Fig. S1A). Here, GSDMD is linked to bronchopulmonary dysplasia.